
                                SEQUENCE LISTING

<110> INDAPTA THERAPEUTICS, INC.

<120> METHODS OF TREATMENT AND DOSING OF NATURAL KILLER CELL COMPOSITIONS
  

<130> 77603-2001240

<140> Not Yet Assigned
<141> Concurrently Herewith

<150> 63177956           
<151> 2021-04-21 

<160> 18

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 86
<212> PRT
<213> Homo sapiens

<220> 
<223> Human FcRy chain (NP_004097.1 (GI:4758344))

<400> 1
Met Ile Pro Ala Val Val Leu Leu Leu Leu Leu Leu Val Glu Gln Ala
 1               5                  10                  15      
Ala Ala Leu Gly Glu Pro Gln Leu Cys Tyr Ile Leu Asp Ala Ile Leu
            20                  25                  30          
Phe Leu Tyr Gly Ile Val Leu Thr Leu Leu Tyr Cys Arg Leu Lys Ile
        35                  40                  45              
Gln Val Arg Lys Ala Ala Ile Thr Ser Tyr Glu Lys Ser Asp Gly Val
    50                  55                  60                  
Tyr Thr Gly Leu Ser Thr Arg Asn Gln Glu Thr Tyr Glu Thr Leu Lys
65                  70                  75                  80  
His Glu Lys Pro Pro Gln
                85      


<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 2
atatttacag aatggcacag g                                           21

<210> 3
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 3
gacttggtac ccaggttgaa                                             20

<210> 4
<211> 32
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 4
atcagattcg atcctacttc tgcagggggc at                               32

<210> 5
<211> 32
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 5
acgtgctgag cttgagtgat ggtgatgttc ac                               32

<210> 6
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 6
cccaactcaa cttcccagtg tgat                                        24

<210> 7
<211> 30
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 7
gaaatctacc ttttcctcta atagggcaat                                  30

<210> 8
<211> 29
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 8
gaaatctacc ttttcctcta atagggcaa                                   29

<210> 9
<211> 28
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 9
gaaatctacc ttttcctcta atagggca                                    28

<210> 10
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 10
ccaaaagcca cactcaaaga c                                           21

<210> 11
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 11
acccaggtgg aaagaatgat g                                           21

<210> 12
<211> 25
<212> DNA
<213> Artificial Sequence

<220> 
<223> Probe

<400> 12
aacatcacca tcactcaagg tttgg                                       25

<210> 13
<211> 25
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 13
ctgaagacac atttttactc ccaaa                                       25

<210> 14
<211> 22
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 14
tccaaaagcc acactcaaag ac                                          22

<210> 15
<211> 25
<212> DNA
<213> Artificial Sequence

<220> 
<223> Primer

<400> 15
ctgaagacac atttttactc ccaac                                       25

<210> 16
<211> 238
<212> PRT
<213> Artificial Sequence

<220> 
<223> CD16 (F158)

<400> 16
Gly Met Arg Thr Glu Asp Leu Pro Lys Ala Val Val Phe Leu Glu Pro
 1               5                  10                  15      
Gln Trp Tyr Arg Val Leu Glu Lys Asp Ser Val Thr Leu Lys Cys Gln
            20                  25                  30          
Gly Ala Tyr Ser Pro Glu Asp Asn Ser Thr Gln Trp Phe His Asn Glu
        35                  40                  45              
Ser Leu Ile Ser Ser Gln Ala Ser Ser Tyr Phe Ile Asp Ala Ala Thr
    50                  55                  60                  
Val Asp Asp Ser Gly Glu Tyr Arg Cys Gln Thr Asn Leu Ser Thr Leu
65                  70                  75                  80  
Ser Asp Pro Val Gln Leu Glu Val His Ile Gly Trp Leu Leu Leu Gln
                85                  90                  95      
Ala Pro Arg Trp Val Phe Lys Glu Glu Asp Pro Ile His Leu Arg Cys
            100                 105                 110         
His Ser Trp Lys Asn Thr Ala Leu His Lys Val Thr Tyr Leu Gln Asn
        115                 120                 125             
Gly Lys Gly Arg Lys Tyr Phe His His Asn Ser Asp Phe Tyr Ile Pro
    130                 135                 140                 
Lys Ala Thr Leu Lys Asp Ser Gly Ser Tyr Phe Cys Arg Gly Leu Phe
145                 150                 155                 160 
Gly Ser Lys Asn Val Ser Ser Glu Thr Val Asn Ile Thr Ile Thr Gln
                165                 170                 175     
Gly Leu Ala Val Ser Thr Ile Ser Ser Phe Phe Pro Pro Gly Tyr Gln
            180                 185                 190         
Val Ser Phe Cys Leu Val Met Val Leu Leu Phe Ala Val Asp Thr Gly
        195                 200                 205             
Leu Tyr Phe Ser Val Lys Thr Asn Ile Arg Ser Ser Thr Arg Asp Trp
    210                 215                 220                 
Lys Asp His Lys Phe Lys Trp Arg Lys Asp Pro Gln Asp Lys
225                 230                 235             


<210> 17
<211> 16
<212> PRT
<213> Artificial Sequence

<220> 
<223> Signal peptide

<400> 17
Met Trp Gln Leu Leu Leu Pro Thr Ala Leu Leu Leu Leu Val Ser Ala
 1               5                  10                  15      


<210> 18
<211> 238
<212> PRT
<213> Artificial Sequence

<220> 
<223> CD16 158V+ (VAR_003960)

<400> 18
Gly Met Arg Thr Glu Asp Leu Pro Lys Ala Val Val Phe Leu Glu Pro
 1               5                  10                  15      
Gln Trp Tyr Arg Val Leu Glu Lys Asp Ser Val Thr Leu Lys Cys Gln
            20                  25                  30          
Gly Ala Tyr Ser Pro Glu Asp Asn Ser Thr Gln Trp Phe His Asn Glu
        35                  40                  45              
Ser Leu Ile Ser Ser Gln Ala Ser Ser Tyr Phe Ile Asp Ala Ala Thr
    50                  55                  60                  
Val Asp Asp Ser Gly Glu Tyr Arg Cys Gln Thr Asn Leu Ser Thr Leu
65                  70                  75                  80  
Ser Asp Pro Val Gln Leu Glu Val His Ile Gly Trp Leu Leu Leu Gln
                85                  90                  95      
Ala Pro Arg Trp Val Phe Lys Glu Glu Asp Pro Ile His Leu Arg Cys
            100                 105                 110         
His Ser Trp Lys Asn Thr Ala Leu His Lys Val Thr Tyr Leu Gln Asn
        115                 120                 125             
Gly Lys Gly Arg Lys Tyr Phe His His Asn Ser Asp Phe Tyr Ile Pro
    130                 135                 140                 
Lys Ala Thr Leu Lys Asp Ser Gly Ser Tyr Phe Cys Arg Gly Leu Val
145                 150                 155                 160 
Gly Ser Lys Asn Val Ser Ser Glu Thr Val Asn Ile Thr Ile Thr Gln
                165                 170                 175     
Gly Leu Ala Val Ser Thr Ile Ser Ser Phe Phe Pro Pro Gly Tyr Gln
            180                 185                 190         
Val Ser Phe Cys Leu Val Met Val Leu Leu Phe Ala Val Asp Thr Gly
        195                 200                 205             
Leu Tyr Phe Ser Val Lys Thr Asn Ile Arg Ser Ser Thr Arg Asp Trp
    210                 215                 220                 
Lys Asp His Lys Phe Lys Trp Arg Lys Asp Pro Gln Asp Lys
225                 230                 235             

